Explore more publications!
Health Herald Grenada
Got News to Share?

Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Ligand to Host Investor Day on December 9, 2025
October 16, 2025

Ligand to Host Investor Day on December 9, 2025

Indeterminate GlobeNewswire
BPGbio Presents Phase 2 Glioblastoma Data on BPM31510 at ESMO 2025
October 16, 2025

BPGbio Presents Phase 2 Glioblastoma Data on BPM31510 at ESMO 2025

Indeterminate GlobeNewswire
Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases
October 16, 2025

Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases

Indeterminate GlobeNewswire
Verano Elevates Expanding Vape Product Portfolio with Exclusive, First-to-Market Launch of Revolutionary HYPHEN System
October 16, 2025

Verano Elevates Expanding Vape Product Portfolio with Exclusive, First-to-Market Launch of Revolutionary HYPHEN System

Indeterminate GlobeNewswire
Cellectis organise aujourd’hui son R&D Day pour présenter les avancées de son portefeuille et ses perspectives à long terme
October 16, 2025

Cellectis organise aujourd’hui son R&D Day pour présenter les avancées de son portefeuille et ses perspectives à long terme

Indeterminate GlobeNewswire
DNA Cancer Vaccine Market Size Clinical Trials FDA Approval Market Opportunity Insight
October 16, 2025

DNA Cancer Vaccine Market Size Clinical Trials FDA Approval Market Opportunity Insight

Indeterminate GlobeNewswire
Aveanna Announces Third Quarter 2025 Earnings Release Date and Conference Call
October 16, 2025

Aveanna Announces Third Quarter 2025 Earnings Release Date and Conference Call

Indeterminate GlobeNewswire
MADD Canada et son partenaire, la Société des alcools de Terre-Neuve-et-Labrador, s’unissent pour lutter contre la conduite avec capacités affaiblies chez les jeunes de la province
October 16, 2025

MADD Canada et son partenaire, la Société des alcools de Terre-Neuve-et-Labrador, s’unissent pour lutter contre la conduite avec capacités affaiblies chez les jeunes de la province

Indeterminate GlobeNewswire
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
October 16, 2025

RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

Indeterminate GlobeNewswire
Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Patients with Refractory Herpes Simplex Virus in Phase 3 Pivotal Trial
October 16, 2025

Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Patients with Refractory Herpes Simplex Virus in Phase 3 Pivotal Trial

Indeterminate GlobeNewswire
ENT and Allergy Associates, LLP Welcomes Ethan Moritz, MD to Its Offices in Woodbury and Voorhees, NJ
October 16, 2025

ENT and Allergy Associates, LLP Welcomes Ethan Moritz, MD to Its Offices in Woodbury and Voorhees, NJ

Indeterminate GlobeNewswire
Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference
October 16, 2025

Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference

Indeterminate GlobeNewswire
AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors
October 16, 2025

AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors

Indeterminate GlobeNewswire
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
October 16, 2025

Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions